Have a personal or library account? Click to login
Sinonasal inverted papilloma associated with squamous cell carcinoma Cover

Sinonasal inverted papilloma associated with squamous cell carcinoma

Open Access
|Oct 2011

Abstract

Background. The aims of the study were to review single-institution experiences with sinonasal inverted papilloma associated with squamous cell carcinoma (IP/SCC), to analyze the presence of human papillomavirus (HPV) and to evaluate the role of radiotherapy.

Patients and methods. Five patients with IP/SCC were identified in the prospective institutional databases (1995-2005) and HPV status was determined in all five tumors.

Results. Four out of five patients had T3-4 tumors; no nodal involvement was seen in any of them. Four patients had curative surgery, supplemented in three of them with radiotherapy. Debulking surgery was performed in the patient with a non-resectable tumor followed by radical radiotherapy. Tumor was controlled locally in three patients at 8, 46 and 58 months post-surgery. Local failure occurred in two patients: after endoscopic resection of a T1 tumor (the recurrent tumor was successfully salvaged with additional surgery) and in a patient with an inoperable tumor. No regional or distant metastases occurred. HPV status was determined in all five tumors and three of them were found positive for HPV type 11.

Conclusions. In operable sinonasal IP/SCC, upfront surgery and postoperative radiotherapy to the tumor bed with dose levels comparable to those used for invasive SCC are recommended. For non-resectable disease, radical radiotherapy to a dose of 66-70 Gy could be of benefit.

DOI: https://doi.org/10.2478/v10019-011-0033-4 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 267 - 272
Published on: Oct 8, 2011
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2011 Jasna But-Hadzic, Klemen Jenko, Mario Poljak, Bostjan Kocjan, Nina Gale, Primoz Strojan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 45 (2011): Issue 4 (December 2011)